Microcap Opportunities

Microcap Opportunities

Share this post

Microcap Opportunities
Microcap Opportunities
Kneat Dominates Life Science Validation Industry

Kneat Dominates Life Science Validation Industry

Sergio Heiber's avatar
Sergio Heiber
Aug 13, 2024
∙ Paid

Share this post

Microcap Opportunities
Microcap Opportunities
Kneat Dominates Life Science Validation Industry
1
Share

Kneat (OTCQX: KSIOF) (TSX:KSI: CA) is a first-mover in digitalizing validation and quality management compliance. In a January Seeking Alpha article, I lauded management's scaling strategy and execution, but my concern with expenses outpacing income resulted in a HOLD rating.

I am upgrading my rating to BUY, as strategy execution remains on target, but a…

Keep reading with a 7-day free trial

Subscribe to Microcap Opportunities to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 MicroCap Opportunities
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share